Incorporation of a novel CD16-specific single-domain antibody into multispecific natural killer cell engagers with potent ADCC

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1021/acs.molpharmaceut.1c00208
AuthorSearch for: 1; Search for: ; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: ; Search for: 1; Search for: 1ORCID identifier: https://orcid.org/0000-0003-0477-0558
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FunderSearch for: National Research Council of Canada
FormatText, Article
Subjectsingle-domain antibody; VHH; nanobody; CD16; natural killer cell; bispecific NK cell engager; cancer immunotherapy
Publication date
PublisherAmerican Chemical Society
Access condition
  • Multispecific antibodies that bridge immune effector and tumor cells have shown promising preclinical and clinical efficacies. Here, we isolated and characterized novel llama single-domain antibodies (sdAbs) against CD16. One sdAb, NRC-sdAb048, bound recombinant human and cynomolgus monkey CD16 ectodomains with equivalent affinity (KD: 1 nM) but did not recognize murine CD16. Binding was similar for human CD16a expressed on NK cells and CD16b (NA2) expressed on neutrophils but dramatically weaker (KD: ∼6 μM) for the CD16b (NA1) allotype. The sdAb stained primary human peripheral blood NK cells. Irrespective of fusion orientation and linker length, bispecific sdAb–sdAb and sdAb–scFv dimers (anti-CD16/EGFR, anti-CD16/HER2, and anti-CD16/CD19) retained full binding affinity for each target, coengaged both antigens simultaneously, elicited ADCC against target antigen-expressing tumor cells in a reporter bioassay, and triggered target-specific activation and degranulation of primary NK cells as measured via interferon-γ and CD107a expression. These molecules may have applications in cancer immunotherapy.
In
LanguageEnglish
Peer reviewedYes
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier5bb9162d-a754-4dd8-9abd-5a2db5bba67b
Record created2023-01-20
Record modified2023-03-16
Date modified: